A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis
2002 ◽
Vol 16
(1)
◽
pp. 61-68
◽
Keyword(s):
1988 ◽
Vol 23
(sup148)
◽
pp. 40-44
◽
2010 ◽
Vol 33
(2)
◽
pp. 194-202
◽
2015 ◽
Vol 110
(5)
◽
pp. 708-715
◽
2003 ◽
Vol 107
(3)
◽
pp. 165-175
◽
2004 ◽
Vol 19
(2)
◽
pp. 135-141
◽
Keyword(s):